Navigation Links
Patients Fare Better With Doctors Who Do More Angioplasty Procedures

The researchers from the University of Michigan Cardiovascular Center had found that the risk of major complications from angioplasty and related procedures lowers when doctors perform a large number of those procedures // each year. The paper is published in the Journal of the American College of Cardiology.

In fact, the risk of major cardiovascular problems was 63 percent higher among patients treated by doctors who performed less than 90 procedures each year, compared with those who did more than 90.

However, the study found no difference in the risk of death before leaving the hospital among patients treated by low- and high-volume doctors. And, it found that a few doctors who performed fewer angioplasties each year still had very good patient outcomes, suggesting that “practice makes perfect” isn’t the whole story for the minimally invasive procedures known as percutaneous coronary interventions (PCI).

The researchers say their data, from 18,504 artery-opening procedures done in 14 Michigan hospitals by 165 physicians during 2002, reflects current angioplasty care, including advanced clot-preventing drugs and devices called stents that hold arteries open after they’re cleared. Both advances, and better technology for deploying stents within an artery, have helped make PCI procedures safer.

The relationship between physician volumes and patient outcomes is not as strong as it used to be, but it’s still present, said the researchers. While a cutoff number may not be enough by itself to predict how well a patient will do, it’s still a useful tool.

In fact, the new study suggests that 90 procedures a year may be a better threshold than 75, the current standard used by national heart groups.

(Source: Newswise)
'"/>




Page: 1

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Amphetamines Help Recovery of Stroke Patients
3. Painkillers Do Not Shorten Dying Patients Lives
4. Patients With Filariasis More Prone To HIV Infection
5. Glivec - New Hope For CMC Patients
6. Patients often assume wrongly that they are allergic to penicillin
7. New FDA Approved Drug NATRECOR For Heart Failure Patients
8. Hemochromatosis Patients Blood is Safe
9. Patients Pressure Would Result In Overprescription
10. Risk Of Decongestants In Hypertensive Patients
11. Interference helps Heart Patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/23/2017)... ... January 23, 2017 , ... Sharon Kleyne, America’s leading water researcher, advocate and ... the benefits of making new water infrastructure a number one priority. “As we usher ... expect water infrastructure to become a top priority of our new political change agents.” ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... Crystallization in Process Chemistry by Applying Simple PAT Tools . , ... to isolate and purify the desired product. Chemists now spend more time ...
(Date:1/23/2017)... ... January 23, 2017 , ... "ProRandom is a set of camera tools that allow video editors ... Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. , ... text with video footage. ProRandom works by using a virtual camera to create the ...
(Date:1/23/2017)... Atlanta, Georgia (PRWEB) , ... January 23, 2017 ... ... leader in providing high-quality general gynecological care and gynecological services for ... to providing personalized care for a wide variety of reproductive services from routine ...
(Date:1/23/2017)... ... January 23, 2017 , ... The ... at seafoodnutrition.org/programs and seafoodnutrition.org/resources to assist in teaching communities and individuals about ... been developed for use by nutrition educators and influencers within the public ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... 23, 2017 A new Transparency Market Research ... was valued at US$0.53 bn in 2013 and is predicted to ... CAGR between 2014 and 2022. The title of the report is ... Share, Growth, Trends and Forecast 2014 - 2022." ... Non-invasive prenatal testing (NIPT), also referred ...
(Date:1/23/2017)... SAN DIEGO and PALMA, ... Laboratoris Sanifit S.L., a clinical-stage biopharmaceutical ... announced that the first patient has been enrolled ... of lead candidate, SNF472, for the treatment of ... haemodialysis (HD). Most ESRD patients, in ...
(Date:1/21/2017)... , Jan 20, 2017 Research and ... Laboratory Testing Market By Type of Test (Tumor, Clinical Chemistry, ... By Type of Diseases (Tuberculosis, Influenza, Cancer, HIV/AIDS etc.), Forecast ... ... destination for healthcare services, market segments, especially clinical lab testing, ...
Breaking Medicine Technology: